ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
132.91
+2.56 (1.96%)
Feb 23, 2026, 4:00 PM EST - Market closed
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $10.12 billion as of February 23, 2026. Its market cap has increased by 2,348.15% in one year.
Market Cap
10.12B
Enterprise Value
9.51B
1-Year Change
2,348.15%
Ranking
Category
Stock Price
$132.91
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $10.12B, an increase of 4,388.49%. That is a compound annual growth rate of 42.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 10.31B | -6.33% |
| Dec 31, 2025 | 11.00B | 2,382.10% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioMarin Pharmaceutical | 12.31B |
| Summit Therapeutics | 12.29B |
| Exelixis | 11.33B |
| Avidity Biosciences | 10.98B |
| Jazz Pharmaceuticals | 10.46B |
| Madrigal Pharmaceuticals | 9.98B |
| Praxis Precision Medicines | 9.34B |
| Axsome Therapeutics | 9.26B |